š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to compare the pharmacokinetics, safety, toler...
Status
Completed
Location
Samsung Investigational Site
Start Date
2014-02
Trial ID
NCT02075073
Treatments Being Tested
In this prospective randomized controlled trial, pediatric volunteers were ...
Status
Unknown
Location
Qilu Children's Hospital
Start Date
2022-10-20
Trial ID
NCT05522101
Treatments Being Tested
A Long-term Follow-up Study for Cardiac Safety in the Patients with HER2 Po...
Status
Terminated
Location
Complex Oncological Center - Vratsa, EOOD
Start Date
2016-04
Trial ID
NCT02771795
Treatments Being Tested
This phase II trial compares the effect of usual treatment of docetaxel che...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-03
Trial ID
NCT05408845
This phase II trial studies how well TPIV100 and sargramostim work in treat...
Status
Unknown
Location
Mayo Clinic in Arizona
Start Date
2020-02-20
Trial ID
NCT04197687
This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2014-02-18
Trial ID
NCT02003209
This clinical trial examines an investigational scan (64Cu-DOTA-trastuzumab...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2022-12-21
Trial ID
NCT05376878
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This is a feasibility, prospective, single center, open label, uncontrolled...
Status
Terminated
Location
Medtronic - Glilee Medical Center
Start Date
2018-04-10
Trial ID
NCT03301909
Treatments Being Tested
A prospective, multicenter, post-market, minimal risk, observational study ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT05450393